Long term use of proton pump inhibitors
Pro Research Analysisby 
Searched over 200M research papers
Long-Term Use of Proton Pump Inhibitors: Risks and Recommendations
Introduction to Proton Pump Inhibitors (PPIs)
Proton pump inhibitors (PPIs) are widely prescribed medications used to treat acid-related disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and for the prevention of NSAID-induced ulcers. While effective in the short term, concerns have been raised about the safety of their long-term use.
Risks Associated with Long-Term PPI Use
Infectious Complications
Long-term use of PPIs has been associated with an increased risk of infectious complications. Studies indicate a higher incidence of Clostridium difficile infections and other enteric infections among long-term PPI users 248. This is likely due to the reduction in gastric acidity, which normally acts as a barrier to pathogens.
Nutritional Deficiencies
Prolonged PPI use can lead to deficiencies in essential nutrients. There is evidence suggesting reduced absorption of vitamins and minerals, including vitamin B12, magnesium, and calcium, which can result in conditions such as hypomagnesemia and osteoporosis 238. However, routine supplementation beyond the Recommended Dietary Allowance (RDA) is not generally advised .
Cardiovascular Health
The impact of long-term PPI use on cardiovascular health has been debated. A meta-analysis found no significant increase in the risk of major adverse cardiovascular events (MACEs) or all-cause mortality among long-term PPI users, although some observational studies suggested a potential risk when PPIs are combined with clopidogrel .
Gastric Cancer and Pre-Malignant Lesions
The relationship between long-term PPI use and gastric cancer remains controversial. Some studies suggest an increased risk of gastric cancer, particularly after Helicobacter pylori eradication . However, other research indicates no clear evidence that PPIs cause or accelerate the progression of pre-malignant gastric lesions, although there may be an increased likelihood of enterochromaffin-like (ECL) cell hyperplasia .
Other Adverse Effects
Additional potential adverse effects of long-term PPI use include an increased risk of chronic kidney disease, dementia, and bone fractures 3910. The evidence for these associations varies, and the clinical significance of some findings remains uncertain.
Recommendations for Long-Term PPI Use
Indications and Dosage
- GERD and Barrett's Esophagus: Patients with GERD and acid-related complications should use PPIs for short-term healing and long-term symptom control. Those with Barrett's esophagus, whether symptomatic or asymptomatic, may require long-term PPI therapy .
- NSAID-Induced Ulcer Prophylaxis: Patients at high risk for ulcer-related bleeding from NSAIDs should continue PPI therapy if they remain on NSAIDs .
Periodic Reevaluation
The dosage of long-term PPIs should be periodically reevaluated to ensure the lowest effective dose is used to manage the condition . Efforts to reduce or discontinue PPI use should be reassessed frequently .
Monitoring and Supplementation
Routine screening or monitoring of bone mineral density, serum creatinine, magnesium, or vitamin B12 is not recommended for long-term PPI users. Similarly, routine use of probiotics to prevent infections is not advised .
Conclusion
While PPIs are effective and generally safe for short-term use, their long-term use is associated with several potential risks, including infections, nutritional deficiencies, and possibly increased risks of certain chronic conditions. It is crucial to periodically reassess the need for continued PPI therapy and to use the lowest effective dose to mitigate these risks.
Sources and full results
Most relevant research papers on this topic